The $2 Trillion Contradiction
Matthew Berman’s video, "Anthropic’s IPO Makes No Sense," lays bare a staggering contradiction at the heart of the AI boom. How does a company like Anthropic, whose very identity hinges on AI safety, simultaneously warn of its technology's potential to "destroy all of humanity" and launch an Initial Public Offering? This isn't just a philosophical debate; it's a live roadshow for a product the company admits it has "no current plan on how to control."
Imagine a CEO in aviation or healthcare, sectors where lives are constantly at stake, announcing to investors: "We're building something potentially catastrophic, and we don't know how to stop it. Now, invest!" Such a statement would instantly brand that individual as irresponsible, if not outright insane. Yet, Anthropic's leadership apparently expects a different reaction from the market, even as they acknowledge grave, unmitigated risks in their S-1 filing.
The financial stakes amplify this cognitive dissonance. Anthropic confidentially filed its IPO documents with the SEC in June 2026, reportedly targeting an astronomical valuation of $2 trillion. This figure doesn't emerge from thin air; it follows a furious succession of funding rounds. Just months prior, a May 2026 Series H round valued the company at an already staggering $965 billion. Investors are pouring unprecedented capital into a future the company itself warns might not exist.
"It Could Kill Us All"
Concern about AI's existential threat extends far beyond Matthew Berman's pointed critique; it comes directly from the creators. Jacob Coxon, a former researcher at both OpenAI and Anthropic, publicly resigned in early September 2026, delivering a chilling assessment. He stated unequivocally that those actively building advanced AI "earnestly believe that it could kill us all by the end of the decade," indicting his former employers for their profoundly irresponsible trajectories.
Anthropic's own internal experts echo this dire premonition with clinical precision. Evan Hubinger, the company’s Alignment Science Lead, publicly estimated the risk of AI-caused human extinction at over 10% within the next decade. This isn't external punditry; it’s a stark admission from inside the very engine room of AI development, quantifying humanity's potential demise as it races towards an IPO.
These insider warnings are not merely whispers among researchers; they are etched into Anthropic's official S-1 filing. The company, in its legal disclosure to the SEC, explicitly acknowledges profound risks to society that its technology poses. It admits it may not be able to fully mitigate these dangers, embedding the specter of uncontained AI risk directly into its bid for a $2 trillion valuation.
The Race to Market vs. The Race to Safety
Anthropic's IPO isn't just a money grab; it's a calculated land grab. They are strategically positioned to be the first pure-play frontier AI lab on the public market, offering investors unprecedented direct exposure to the generative AI economy. With a targeted $2 trillion valuation and an annualized revenue run rate exceeding $65 billion by July 2026, this move capitalizes on massive investor appetite. Anthropic aims for a public listing as early as October 2026, a bold timeline for a company simultaneously warning of humanity's potential destruction.
This aggressive timeline sharply contrasts with rival OpenAI, which has deliberately delayed its own public offering, despite similar technological advancements. The differing approaches reveal a fundamental split in how top labs are approaching public accountability: Anthropic embraces immediate market scrutiny, while OpenAI opts for a more controlled, private trajectory.
Anthropic, however, counters that the rigorous transparency and public reporting required of an IPO could actually strengthen its accountability to its safety-first mission. They argue the intense public and regulatory oversight provides a powerful external check on their development, ensuring their commitment to building safe AI isn't merely corporate rhetoric. For further reading on this unprecedented move, see Anthropic moving forward with $2 trillion IPO on Nasdaq - Quartz.
Enjoying this? Get one like it in your inbox each morning.
one email a day · unsubscribe in two clicks · no third-party tracking
Investing in the Apocalypse?
Investing in the apocalypse presents a stark ethical and financial dilemma. Can Anthropic, a company publicly warning of humanity's destruction, simultaneously serve a public benefit mission and the profit-maximizing demands of shareholders aiming for a $2 trillion valuation? Matthew Berman's video, "Anthropic’s IPO Makes No Sense," rightly questions this logic, likening a CEO making such statements on a roadshow to "crazy" behavior in any other risk-averse sector.
Third-party concerns echo this tension. Morningstar, for instance, explicitly called for S-1 filings to detail 'protective mechanisms' that ensure long-term accountability, especially given the acknowledged societal risks. Without clear, enforceable safeguards beyond mere corporate statements, investors are asked to fund a future whose architects admit they Can't control it, a contradiction many find untenable.
This confidential S-1 filing, leading to an anticipated October 2026 public listing, positions Anthropic's IPO as more than a financial event. It becomes a critical test case for the entire AI industry, forcing a reckoning with its ability to balance immense power and unprecedented profit potential with fundamental public responsibility. The world watches to see if the market will demand safety alongside returns.
Frequently Asked Questions
What is Anthropic's expected IPO valuation?
Anthropic is reportedly targeting a valuation of around $2 trillion for its upcoming Initial Public Offering, which is anticipated as early as October 2026.
Why is the Anthropic IPO considered controversial?
The controversy stems from the company publicly warning that its technology could pose an existential risk to humanity while simultaneously asking for public investment, a move critics find deeply contradictory.
How does Anthropic's IPO strategy differ from OpenAI's?
While Anthropic is pushing forward with its IPO, rival OpenAI has stated a 2026 public offering would be ill-advised amid the intense AI safety debate, highlighting a significant divergence in their approaches to public markets.
What is Anthropic's official stance on AI safety?
Founded on AI safety principles, Anthropic's core mission is that safe and useful AI are intertwined. The company has explicitly included warnings about its technology's potential societal risks in its S-1 IPO filing.

